secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001683168-23-008732
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio raises $2.8M via warrant exercise at $1.33, issues new warrants at $1.08
-----------------------------------------------------------------------------

- Existing warrant holders exercise 2,130,252 shares at reduced price of $1.33/share; gross proceeds ~$2.8M.
- Phio issues new unregistered Series A and Series B warrants to purchase up to 4,260,504 shares at $1.08/share.
- Series A warrants have a 5.5-year term; Series B warrants have an 18-month term.
- H.C. Wainwright serves as exclusive placement agent; receives 7.5% cash fee and 159,769 placement agent warrants.
- Net proceeds intended for working capital and general corporate purposes; offering expected to close Dec 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823008732/0001683168-23-008732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316823008732/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer